NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | -100.0% | 39 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $11,844,000 | +12.3% | 194,290 | -10.1% | 0.29% | +10.9% |
| Q2 2018 | $10,547,000 | -37.5% | 215,999 | +36.1% | 0.26% | -30.8% |
| Q1 2018 | $16,864,000 | -17.0% | 158,707 | -53.4% | 0.37% | -8.1% |
| Q4 2017 | $20,329,000 | +13.6% | 340,403 | -54.4% | 0.41% | +11.8% |
| Q3 2017 | $17,903,000 | +24.9% | 745,979 | +1.8% | 0.36% | +37.0% |
| Q2 2017 | $14,331,000 | -16.0% | 733,030 | +0.9% | 0.26% | -12.3% |
| Q1 2017 | $17,055,000 | +86.5% | 726,653 | -2.5% | 0.30% | +108.3% |
| Q4 2016 | $9,144,000 | -21.0% | 745,229 | +10.6% | 0.14% | -10.5% |
| Q3 2016 | $11,571,000 | -2.6% | 673,520 | -19.3% | 0.16% | 0.0% |
| Q2 2016 | $11,876,000 | +0.3% | 834,589 | -3.1% | 0.16% | +9.5% |
| Q1 2016 | $11,838,000 | -20.7% | 860,991 | -2.8% | 0.15% | -9.2% |
| Q4 2015 | $14,919,000 | +29.5% | 885,417 | -15.8% | 0.16% | +33.6% |
| Q3 2015 | $11,523,000 | -18.1% | 1,051,447 | -6.5% | 0.12% | +1.7% |
| Q2 2015 | $14,068,000 | +17.4% | 1,124,589 | +3.3% | 0.12% | +26.3% |
| Q1 2015 | $11,979,000 | -29.2% | 1,089,075 | -0.3% | 0.10% | -24.0% |
| Q4 2014 | $16,923,000 | +14.2% | 1,091,833 | -11.1% | 0.12% | +15.7% |
| Q3 2014 | $14,816,000 | -17.2% | 1,227,587 | -12.1% | 0.11% | -11.5% |
| Q2 2014 | $17,899,000 | +9.0% | 1,396,249 | +3.0% | 0.12% | +8.0% |
| Q1 2014 | $16,423,000 | -11.7% | 1,355,059 | -17.3% | 0.11% | -16.9% |
| Q4 2013 | $18,607,000 | +6.6% | 1,639,423 | -1.9% | 0.14% | -1.4% |
| Q3 2013 | $17,462,000 | +5.0% | 1,671,887 | +16.1% | 0.14% | -3.5% |
| Q2 2013 | $16,632,000 | – | 1,440,078 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |